Luis Alvarez received the 1968 physics prize for research on elementary particle physics. But did you know he and his geologist son, Walter, published the theory that dinosaurs became extinct after an asteroid collided with Earth 65 million years ago?

x.com/i/article/1941…

Ronald P. Karlsberg MD FACP FAHA FACC MSCCT | Eric Topol We do have ongoing research looking exactly at this issue and you can get a PGR through Pradeep Natarajan at Polygenic Risk Test | Mass General Brigham: massgeneralbrigham.org/en/research-an… Cleerly Heart_SCCT #cardiact #coronarycta

Wow...it is that time again. Gearing up for a great Heart_SCCT ASM #SCCT2025 in Montreal!

🏆 SCCT Best Original Science Award goes to Dr. Joel Lenell, MD, PhD at the 20th Annual Heart_SCCT Scientific Meeting! Supported by CVRFSoCal and CVMG His winning abstract: “Intensive Medical Treatment Reduces Non-calcified Coronary Plaque in Women With

🏅 Huge congratulations to Joel Lenell for winning the Best Abstract Award at the Heart_SCCT 20th Annual Scientific Meeting! From: Cedars-Sinai Cedars-Sinai Cardiology Fellowship Eduardo Marban, MD, PhD Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Smidt Heart Institute at Cedars-Sinai Cardiac Wire Supported by CVRFSoCal His AI-enabled plaque analysis in

We are pleased to report: 🏆 SCCT Best Original Science Award goes to Dr. Joel Lenell, MD, PhD Joel Lenell at the 20th Annual Heart_SCCT Scientific Meeting! Supported by CVRFSoCal and CVMG See the entire competition at youtube.com/watch?v=0lU0AH… #scct2025. Also

daniel karlsberg presents the groundbreaking work of the CVRFSoCal at #SCCT2025. From AI imaging to cutting edge CT research and gene silencing for #coronaryartery disease. CVRF is driving the future. Heart_SCCT NYU CVD Prevention Chamath Palihapitiya Robert F. Kennedy Jr Andrew Keys

Excited about daniel karlsberg's presentation of CVRFSoCal's groundbreaking work at #SCCT2025 — from AI-powered imaging and advanced CT research to gene-silencing therapies for coronary artery disease. This is shaping the future of heart health! Heart_SCCT Andrew Keys

x.com/i/article/1950…

x.com/i/article/1952…

x.com/i/article/1954…

Excited for this amazing course!

x.com/i/article/1954…

AI is getting as good as a leading cardiologist I plugged in my results from CTA scan and compared to the notes from my cardiologist

For all of you who stop after the presentation: nothing is more true than the lesson in this image. So many abstracts are never published, and of those that are, the interpretation almost always changes, sometimes radically.

x.com/i/article/1959…

What do you think? Event reduction: In major trials (COLCOT, LoDoCo2), colchicine lowered heart attack and stroke risk in patients with coronary disease, regardless of cholesterol level. While these weren’t Lp(a)-specific studies, the biology suggests patients with high Lp(a)

Ronald P. Karlsberg MD FACP FAHA FACC MSCCT | Bottom line: Low-dose colchicine (0.5 mg daily) cuts ischemic events in post-MI and chronic CAD—even without lowering LDL. No randomized controlled trial yet in high Lp(a), but the inflammation biology supports potential benefit. Sam Tsimikas, MD Pablo Corral MD Dr Paddy Barrett Siim Land